Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy-Reference-Cited by-同舟云学术

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

Published:2019-07-17 Issue:7769 Volume:572 Page:335-340
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Lee Jaecheol,Termglinchan Vittavat,Diecke Sebastian,Itzhaki Ilanit,Lam Chi Keung,Garg Priyanka,Lau Edward,Greenhaw Matthew,Seeger Timon,Wu Haodi,Zhang Joe Z.,Chen Xingqi,Gil Isaac Perea,Ameen Mohamed,Sallam Karim,Rhee June-Wha,Churko Jared M.,Chaudhary Rinkal,Chour Tony,Wang Paul J.,Snyder Michael P.,Chang Howard Y.,Karakikes Ioannis,Wu Joseph C.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1406-x.pdf

Reference44 articles.

1. Carmosino, M. et al. Role of nuclear lamin A/C in cardiomyocyte functions. Biol. Cell 106, 346–358 (2014).

2. Fatkin, D. et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341, 1715–1724 (1999).

3. Krohne, G. & Benavente, R. The nuclear lamins. Exp. Cell Res. 162, 1–10 (1986).

4. Hershberger, R. E. & Morales, A. in GeneReviews (eds Pagon, R. A. et al.) (University of Washington, 1993).

5. Hershberger, R. E., Hedges, D. J. & Morales, A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 10, 531–547 (2013).

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials in-a-dish for cardiovascular medicine;European Heart Journal;2024-09-13

3. Toward the latest advancements in cardiac regeneration using induced pluripotent stem cells (iPSCs) technology: approaches and challenges;Journal of Translational Medicine;2024-08-22

4. Lamin A/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model;Nature Communications;2024-08-14

5. The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models;Pharmaceuticals;2024-08-05